| Metric | Q4'25 | Q1'26 | Change |
|---|---|---|---|
| Total Revenue | $2.09B (+10% YoY) | $1.85B (+8% YoY) | Normal Q4-Q1 seasonality but growth decelerated 200 bps |
| Organic Revenue | +3% YoY | -2% YoY | 500 bps deceleration, first negative since recovery began |
| Adjusted EPS | $0.96 (+14% YoY) | $0.77 (+7% YoY) | Growth rate halved, missing street momentum |
| Adjusted EBITDA Margin | 27.7% | 25.4% | 230 bps compression, driven by ITS deterioration |
| ITS Revenue | +11% YoY | +7% YoY | 400 bps deceleration in growth |
| ITS EBITDA Margin | 28.9% | 26.7% | 220 bps compression, 5th consecutive quarter of decline |
| PST Revenue | +8% YoY | +7% YoY (organic +4%) | Stable growth with strong organic component |
| PST EBITDA Margin | 30.4% | 29.2% | 120 bps decline but still outperforming ITS |
| Free Cash Flow | $462M | $163M | Normal Q1 working capital seasonality but concerning magnitude |
| Book-to-Bill | 0.93x | 1.07x | Strong improvement suggests backlog building |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.